Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.660
+0.110 (2.42%)
May 16, 2025, 2:08 PM - Market open

Precision BioSciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2016 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
492945132450438
Upgrade
Market Cap Growth
-46.69%-34.32%-66.30%-70.64%2.74%-37.95%
Upgrade
Enterprise Value
-8-42-54-53301345
Upgrade
Last Close Price
4.553.8110.9535.70222.00250.20
Upgrade
PE Ratio
-4.08----
Upgrade
PS Ratio
0.700.430.915.263.8918.02
Upgrade
PB Ratio
0.660.522.362.194.939.85
Upgrade
P/TBV Ratio
0.860.522.412.215.0510.17
Upgrade
EV/Sales Ratio
----2.6014.19
Upgrade
Debt / Equity Ratio
0.530.531.660.410.100.24
Upgrade
Asset Turnover
-0.460.250.110.640.13
Upgrade
Quick Ratio
-5.882.353.194.012.33
Upgrade
Current Ratio
-6.342.733.344.502.47
Upgrade
Return on Equity (ROE)
-19.05%-107.26%-96.19%-45.14%-119.30%
Upgrade
Return on Assets (ROA)
--11.04%-13.74%-17.32%-13.61%-35.62%
Upgrade
Return on Capital (ROIC)
-35.62%-23.95%-40.34%-41.95%-31.71%-71.04%
Upgrade
Earnings Yield
-45.60%24.52%-137.79%-84.55%-6.80%-24.91%
Upgrade
FCF Yield
--200.83%-193.42%-37.16%-3.54%-21.12%
Upgrade
Buyback Yield / Dilution
-88.81%-79.20%-31.11%-49.77%-12.79%-23.91%
Upgrade
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q